HCA Healthcare (NYSE:HCA) PT Raised to $438.00 at UBS Group

HCA Healthcare (NYSE:HCA) had its price target raised by investment analysts at UBS Group from $405.00 to $438.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group’s target price would suggest a potential upside of 18.74% from the company’s previous close.

A number of other research analysts have also recently commented on HCA. Baird R W raised HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Cantor Fitzgerald restated an “overweight” rating and issued a $335.00 target price on shares of HCA Healthcare in a research report on Wednesday, July 24th. SVB Leerink increased their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. JPMorgan Chase & Co. increased their target price on shares of HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a report on Thursday, May 30th. Finally, Barclays upped their price target on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research report on Wednesday, July 24th. Four research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $349.28.

HCA Healthcare Trading Up 2.1 %

HCA Healthcare stock opened at $368.86 on Wednesday. HCA Healthcare has a fifty-two week low of $215.96 and a fifty-two week high of $369.41. The firm’s fifty day moving average price is $338.32 and its 200-day moving average price is $327.32. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The stock has a market cap of $96.61 billion, a P/E ratio of 18.39, a PEG ratio of 1.39 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. During the same period in the prior year, the business earned $4.29 earnings per share. HCA Healthcare’s revenue for the quarter was up 10.3% compared to the same quarter last year. Equities research analysts forecast that HCA Healthcare will post 22.43 earnings per share for the current fiscal year.

Insider Transactions at HCA Healthcare

In related news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the transaction, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at $3,436,623.54. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the transaction, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,844 shares of company stock valued at $3,185,932. Company insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

Several institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. increased its stake in HCA Healthcare by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after purchasing an additional 60,304 shares in the last quarter. Sanders Capital LLC lifted its position in HCA Healthcare by 4.2% in the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after acquiring an additional 456,738 shares in the last quarter. Wellington Management Group LLP raised its position in HCA Healthcare by 1.7% in the 4th quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock worth $2,757,181,000 after buying an additional 170,560 shares during the last quarter. Royal Bank of Canada increased its position in HCA Healthcare by 35.7% during the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after acquiring an additional 1,183,890 shares during the last quarter. Finally, Capital World Investors increased its holdings in HCA Healthcare by 57.5% during the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after buying an additional 1,019,750 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.